Ledger.Open graph →
SEC Form D · filed January 29, 2015

Aldeyra Therapeutics, Inc

Offering
$18.4M
Sold
$7.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Scott L. Young · Lexington, MAExecNeal J. Walker · Lexington, MADirectorBen J. Bronstein · Lexington, MADirectorTodd C. Brady · Lexington, MAExec · DirectorStephen C. Tulipano · Lexington, MAExecMartin J. Joyce · Lexington, MADirectorJesse I. Treu · Lexington, MADirectorGary J. Phillips · Lexington, MADirectorC. Boyd L. Clarke · Lexington, MADirectorCormac L. Sheehan · Grand Cayman, Cayman IslandsExecJesse I. Treu · Lexington, MADirectorNancy Kukacka · SAN FRANCISCO, CADirectorScott L. Dakers · Grand Cayman, Cayman IslandsExec · DirectorNicholas L. Lane · Road Town, Tortola, British Virgin IslandsExec · DirectorMichael J. Howe · Philadelphia, PAExec · DirectorDavid A. Achey · Philadelphia, PADirectorJoseph M. Manko, Jr · Philadelphia, PADirectorBradley D. Ginesin · Kent Cliffs, NYExec · DirectorBen J. Bronstein · Lexington, MADirectorMartin J. Joyce · Lexington, MAExec · DirectorC. Boyd L. Clarke · Lexington, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗